Catalent increases sterile fill/finish capacity

摘要

Catalent Pharma Solutions has completed the construction of its newly renovated 3,300ft~2 aseptic fill/finish manufacturing facility at Research Triangle Park (RTP), North Carolina, US. Catalent has a comprehensive sterile product formulation and development offering at its RTP site, where the product development group conducts preformulation, formulation development, process development and manufacturing support in addition to full service analytical development and stability capabilities.